The past few years have seen significant changes in the management of liver cancer and the Single Topic Workshop initiative was established in recognition of the rapidly changing therapeutic landscape. Each STW will focus on a specific area in which recent developments have transformed the field of HCC. ILCA aims to provide delegates with state-of-the-art lectures delivered by leading experts and anticipate that these meetings will be of interest to all disciplines engaged in delivering care to patients with liver cancer.
Discuss recent advances in risk stratification and concepts of precision screening
Learn about proven and proposed strategies for chemoprevention
Hear about emerging biomarker and radiomic strategies for HCC screening, diagnosis, and prognostication
Engage with experts about emerging concepts in HCC surveillance and how best to promote early detection
Discuss patient and industry perspectives on HCC risk stratification and early detection